Clinical Trials Logo
  1. Home
  2. Transplant
  3. NCT00436384

Cell Mediated Immunity and the Prediction of CMV Infection In Solid Organ Transplant Recipients

Transplant Clinical Trial

Official title:
Cell Mediated Immunity and the Prediction of CMV Infection In Solid Organ Transplant Recipients

Clinical Trial Summary

Cytomegalovirus (CMV) is a common cause of illness in patients who have undergone a transplant. Serious infections due to CMV can affect many parts of the body including the lungs, the gut, and the liver. Since transplant recipients are at risk for CMV or have evidence of infection with CMV, they are given an antiviral drug (usually ganciclovir or valganciclovir). Despite this, there are a chance that CMV infection may cause problems in the future. The purpose of this study is to assess how well patients'immune systems responds to the CMV virus, so that in the future it may be possible to predict which patients are at highest risk of CMV.

Clinical Trial Description

n/a

Study Design

N/A

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00436384
Study type Observational
Source University Health Network, Toronto
Contact
Status Completed
Phase Phase 4
Start date November 2005
Completion date March 2008
View Details
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05047068 - OCS Heart Perfusion Post-Approval Registry
Completed NCT03455062 - Fertility Study of Women Who Received Organ Transplantation N/A
Terminated NCT05033548 - Technology Enabled And Molecular Monitoring of the Allograft and Transplant rEcipient
Recruiting NCT04182607 - Donor Outcomes Following Hand-Assisted And Robotic Living Donor Nephrectomy: A Retrospective Review
Completed NCT01022905 - Vaccine Responses to Influenza A H1N1/09 Immunization in High-risk Patients Phase 4
Active, not recruiting NCT03691220 - Improving Medication Adherence in Adolescents Who Had a Liver Transplant N/A
Completed NCT00571818 - The Prospective Evaluation of Pancreatic Function in Pancreas Transplant Recipients N/A
Terminated NCT00884039 - Anecortave Acetate Injection to Treat Steroid-responsive Intraocular Pressure Increase in Cornea Transplant Patients N/A
Completed NCT00677677 - Safety and Immunogenicity of Human Papillomavirus (HPV) Vaccine in Solid Organ Transplant Recipients Phase 3
Completed NCT03860818 - Improving Transplant Medication Safety Through A Technology and Pharmacist Intervention N/A
Recruiting NCT04626167 - Concomitant Renal and Urinary Bladder Allograft Transplantation Early Phase 1
Completed NCT01389804 - Parents of Pediatric Solid Organ Transplant Recipients: Transition to Home and Chronic Illness Care N/A
Recruiting NCT04390724 - Optimizing Y90 Therapy for Radiation Lobectomy
Not yet recruiting NCT04690036 - PD-1 Antibody for Reactive EBV After BMT Early Phase 1
Active, not recruiting NCT00152802 - Pneumonia Vaccine in Liver Transplant Recipients: a Booster Strategy Using a Conjugate Vaccine Phase 4
Not yet recruiting NCT05951231 - Liver Transplantation After ex Vivo Liver Perfusion N/A
Completed NCT00242099 - Clinical Utility of Monitoring for Human Herpesvirus-6 (HHV-6) and Human Herpesvirus-7 (HHV-7) After Liver Transplant Phase 4
Recruiting NCT05717842 - Simultaneous Prospective Kidney Transplant Assessment in Combined Liver Kidney Candidates
Active, not recruiting NCT05655546 - ImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised Individuals N/A
Recruiting NCT06161454 - Xofluza-Wearables Feasibility-Study Phase 4